Danielle Anderson to Influenza A Virus, H3N2 Subtype
This is a "connection" page, showing publications Danielle Anderson has written about Influenza A Virus, H3N2 Subtype.
Connection Strength
0.138
-
Identification and in vivo Efficacy Assessment of Approved Orally Bioavailable Human Host Protein-Targeting Drugs With Broad Anti-influenza A Activity. Front Immunol. 2019; 10:1097.
Score: 0.138